ANGELIQUE GERONIMO: Open Payments
NPI 1316648132 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,767 in 101 payments from 15 companies in 2025. Trend: 2023 $587 · 2024 $1,919 · 2025 $2,767
Food & beverage: $2,767
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $812 |
| Janssen Biotech, Inc. | 8 | $274 |
| Madrigal Pharmaceuticals | 10 | $261 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $259 |
| Phathom Pharmaceuticals, Inc. | 2 | $226 |
| PFIZER INC. | 11 | $222 |
| GENZYME CORPORATION | 6 | $183 |
| Aimmune Therapeutics, Inc. | 10 | $152 |
| Celltrion USA Inc. | 5 | $118 |
| Novo Nordisk Inc | 1 | $99 |
Products named: SKYRIZI, TREMFYA, REZDIFFRA, XIFAXAN, VOQUEZNA, DUPIXENT, RINVOQ, VELSIPITY.
Industry payments across TX — which companies pay providers there.
